Insights Management Platform

Sales & Marketing

Within3’s disease community analytics provide an understanding of influence within a disease community – not just expertise.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.